177 related articles for article (PubMed ID: 7797466)
21. The role of cleavage of the light chain at positions Arg1689 or Arg1721 in subunit interaction and activation of human blood coagulation factor VIII.
Donath MS; Lenting PJ; van Mourik JA; Mertens K
J Biol Chem; 1995 Feb; 270(8):3648-55. PubMed ID: 7876103
[TBL] [Abstract][Full Text] [Related]
22. Activation of human factor IX (Christmas factor).
Di Scipio RG; Kurachi K; Davie EW
J Clin Invest; 1978 Jun; 61(6):1528-38. PubMed ID: 659613
[TBL] [Abstract][Full Text] [Related]
23. Zymogen factor IX potentiates factor IXa-catalyzed factor X activation.
London FS; Walsh PN
Biochemistry; 2000 Aug; 39(32):9850-8. PubMed ID: 10933803
[TBL] [Abstract][Full Text] [Related]
24. Activation of normal and abnormal human factor IX with trypsin.
Monroe DM; Noyes CM; Straight DL; Roberts HR; Griffith MJ
Arch Biochem Biophys; 1985 May; 238(2):490-6. PubMed ID: 3873217
[TBL] [Abstract][Full Text] [Related]
25. Blood clotting factor IX BM Nagoya. Substitution of arginine 180 by tryptophan and its activation by alpha-chymotrypsin and rat mast cell chymase.
Suehiro K; Kawabata S; Miyata T; Takeya H; Takamatsu J; Ogata K; Kamiya T; Saito H; Niho Y; Iwanaga S
J Biol Chem; 1989 Dec; 264(35):21257-65. PubMed ID: 2592373
[TBL] [Abstract][Full Text] [Related]
26. Active-site mapping of bovine and human blood coagulation serine proteases using synthetic peptide 4-nitroanilide and thio ester substrates.
Cho K; Tanaka T; Cook RR; Kisiel W; Fujikawa K; Kurachi K; Powers JC
Biochemistry; 1984 Feb; 23(4):644-50. PubMed ID: 6370301
[TBL] [Abstract][Full Text] [Related]
27. A monoclonal antibody to factor IX that inhibits the factor VIII:Ca potentiation of factor X activation.
Bajaj SP; Rapaport SI; Maki SL
J Biol Chem; 1985 Sep; 260(21):11574-80. PubMed ID: 3930478
[TBL] [Abstract][Full Text] [Related]
28. Identification of a binding site for blood coagulation factor IXa on the light chain of human factor VIII.
Lenting PJ; Donath MJ; van Mourik JA; Mertens K
J Biol Chem; 1994 Mar; 269(10):7150-5. PubMed ID: 8125924
[TBL] [Abstract][Full Text] [Related]
29. Factor IX activation by factor XIa proceeds without release of a free intermediate.
Wolberg AS; Morris DP; Stafford DW
Biochemistry; 1997 Apr; 36(14):4074-9. PubMed ID: 9100000
[TBL] [Abstract][Full Text] [Related]
30. Baculovirus-mediated expression of the epidermal growth factor-like modules of human factor IX fused to the factor XIIIa transamidation site in fibronectin. Evidence for a direct interaction between the NH2-terminal epidermal growth factor-like module of factor IXa beta and factor X.
Astermark J; Sottile J; Mosher DF; Stenflo J
J Biol Chem; 1994 Feb; 269(5):3690-7. PubMed ID: 7906269
[TBL] [Abstract][Full Text] [Related]
31. Coagulation factor IX residues G4-Q11 mediate its interaction with a shared factor IX/IXa binding site on activated platelets but not the assembly of the functional factor X activating complex.
Ahmad SS; Wong MY; Rawala R; Jameson BA; Walsh PN
Biochemistry; 1998 Feb; 37(6):1671-9. PubMed ID: 9484238
[TBL] [Abstract][Full Text] [Related]
32. Proteolytic interactions of factor IXa with human factor VIII and factor VIIIa.
Lamphear BJ; Fay PJ
Blood; 1992 Dec; 80(12):3120-6. PubMed ID: 1467518
[TBL] [Abstract][Full Text] [Related]
33. Kinetics of coagulation factor X activation by platelet-bound factor IXa.
Rawala-Sheikh R; Ahmad SS; Ashby B; Walsh PN
Biochemistry; 1990 Mar; 29(10):2606-11. PubMed ID: 2110473
[TBL] [Abstract][Full Text] [Related]
34. Regulation of factor IXa in vitro in human and mouse plasma and in vivo in the mouse. Role of the endothelium and the plasma proteinase inhibitors.
Fuchs HE; Trapp HG; Griffith MJ; Roberts HR; Pizzo SV
J Clin Invest; 1984 Jun; 73(6):1696-703. PubMed ID: 6202716
[TBL] [Abstract][Full Text] [Related]
35. Activation of factor IX zymogen results in exposure of a binding site for low-density lipoprotein receptor-related protein.
Neels JG; van Den Berg BM; Mertens K; ter Maat H; Pannekoek H; van Zonneveld AJ; Lenting PJ
Blood; 2000 Nov; 96(10):3459-65. PubMed ID: 11071642
[TBL] [Abstract][Full Text] [Related]
36. Characterization of Novel Forms of Coagulation Factor XIa: independence of factor XIa subunits in factor IX activation.
Smith SB; Verhamme IM; Sun MF; Bock PE; Gailani D
J Biol Chem; 2008 Mar; 283(11):6696-705. PubMed ID: 18192270
[TBL] [Abstract][Full Text] [Related]
37. The kinetic assembly of the intrinsic bovine factor X activation system.
Beals JM; Chibber BA; Castellino FJ
Arch Biochem Biophys; 1989 Feb; 268(2):485-501. PubMed ID: 2492418
[TBL] [Abstract][Full Text] [Related]
38. Inhibition of activated porcine factor IX by dansyl-glutamyl-glycyl-arginyl-chloromethylketone.
Lollar P; Fass DN
Arch Biochem Biophys; 1984 Sep; 233(2):438-46. PubMed ID: 6435527
[TBL] [Abstract][Full Text] [Related]
39. Isolation and characterization of a cDNA coding for human factor IX.
Kurachi K; Davie EW
Proc Natl Acad Sci U S A; 1982 Nov; 79(21):6461-4. PubMed ID: 6959130
[TBL] [Abstract][Full Text] [Related]
40. Amphipathic helices support function of blood coagulation factor IXa.
Blostein MD; Rigby AC; Furie BC; Furie B; Gilbert GE
Biochemistry; 2000 Oct; 39(39):12000-6. PubMed ID: 11009614
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
